![Pieter de Geus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pieter de Geus
Directeur/Membre du Conseil chez
Neuroplast BV
Health Technology
Profil
Pieter de Geus currently works at Prothya Biosolutions Belgium BV, as Director from 2020, Alveron Pharma BV, as Member-Supervisory Board, and Neuroplast BV, as Member-Supervisory Board from 2021.
Postes actifs de Pieter de Geus
| Sociétés | Poste | Début |
|---|---|---|
Neuroplast BV
 Neuroplast BV BiotechnologyHealth Technology Develops neuron-regenerative medicines | Directeur/Membre du Conseil | 21/10/2021 |
Alveron Pharma BV
 Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Develops cyclodextrin-based drugs | Directeur/Membre du Conseil | - |
Prothya Biosolutions Belgium BV
 Prothya Biosolutions Belgium BV BiotechnologyHealth Technology Develops, manufactures and sells plasma-derived products & therapies | Directeur/Membre du Conseil | 31/12/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Alveron Pharma BV
Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Develops cyclodextrin-based drugs | Health Technology |
Neuroplast BV
Neuroplast BV BiotechnologyHealth Technology Develops neuron-regenerative medicines | Health Technology |
Prothya Biosolutions Belgium BV
Prothya Biosolutions Belgium BV BiotechnologyHealth Technology Develops, manufactures and sells plasma-derived products & therapies | Health Technology |
